MiRNA-27a-3p Induces Temozolomide Resistance in Glioma by Inhibiting NF1 Level

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2020 Sep 11

PMID 32913547

Citations 5

Authors

Shenglan Li

Wei Li

Gang Chen

Jing Huang

Wenbin Li

Affiliations

Soon will be listed here.

Abstract

To elucidate the role of miRNA-27a-3p in inducing Temozolomide (TMZ) resistance in glioma and the underlying mechanism. Relative levels of miRNA-27a-3p and NF1 in glioma tissues and peritumoral ones were detected. In addition, their levels in TMZ-sensitive and TMZ-resistant glioma tissues were examined as well. TMZ-resistant glioma cell lines SHG44-TG and U87-TR were used for experiments. Relative levels of miRNA-27a-3p and NF1 in TMZ-resistant glioma cells and their parental cells were determined. Subsequently, regulatory effects of miRNA-27a-3p on IC value of TMZ, viability and migratory ability in SHG44-TG and U87-TR cells were assessed. The interaction between miRNA-27a-3p and NF1 was evaluated by luciferase assay and Western blot. MiRNA-27a-3p was upregulated in glioma tissues than controls, especially TMZ-resistant ones, whereas NF-1 displayed a negative correlation to miRNA-27a-3p as its downstream target. Overexpression of miRNA-27a-3p increased IC value of TMZ, viability and migratory ability in SHG44-TG and U87-TR cells. Regulatory effects of miRNA-27a-3p on phenotypes of TMZ-resistant glioma cells were abolished by overexpression of NF1. MiRNA-27a-3p induces TMZ resistance in glioma by negatively regulating NF1 level.

Citing Articles

Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance.

Lan B, Zhuang Z, Zhang J, He Y, Wang N, Deng Z Cell Death Dis. 2024; 15(8):552.

PMID: 39090107 PMC: 11294582. DOI: 10.1038/s41419-024-06936-8.

miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM).

He Z, Cheng M, Hu J, Liu L, Liu P, Chen L J Transl Med. 2022; 20(1):443.

PMID: 36183123 PMC: 9526964. DOI: 10.1186/s12967-022-03647-6.

Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.

Chen L, Li Z, Hu S, Deng Q, Hao P, Guo S Cancer Chemother Pharmacol. 2022; 89(2):217-229.

PMID: 35039898 DOI: 10.1007/s00280-021-04392-1.

Circ_0001588 Upregulates ERBB4 to Promote Glioma Malignant Progression Through Sponging miR-1281.

Wang J, Li J, Duan P, Dang Y, Shi T Neurotox Res. 2022; 40(1):89-102.

PMID: 34982356 DOI: 10.1007/s12640-021-00464-5.

miR-338-5p-ZEB2 axis in Diagnostic, Therapeutic Predictive and Prognostic Value of Gastric Cancer.

Wei X, Zhu J, Zhang Y, Zhao Q, Wang H, Gu K J Cancer. 2021; 12(22):6756-6772.

PMID: 34659565 PMC: 8518007. DOI: 10.7150/jca.58249.

References

McDaneld T, Smith T, Doumit M, Miles J, Coutinho L, Sonstegard T . MicroRNA transcriptome profiles during swine skeletal muscle development. BMC Genomics. 2009; 10:77. PMC: 2646747. DOI: 10.1186/1471-2164-10-77. View

Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K . miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol. 2012; 42(2):757-66. DOI: 10.3892/ijo.2012.1742. View

Lal A, Navarro F, Maher C, Maliszewski L, Yan N, ODay E . miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol Cell. 2009; 35(5):610-25. PMC: 2757794. DOI: 10.1016/j.molcel.2009.08.020. View

Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D . Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987; 236(4805):1100-2. DOI: 10.1126/science.3107130. View

Hu B, Mao Z, Du Q, Jiang X, Wang Z, Xiao Z . miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma. Brain Res Bull. 2019; 149:21-31. DOI: 10.1016/j.brainresbull.2019.03.013. View

Philpott C, Tovell H, Frayling I, Cooper D, Upadhyaya M . The NF1 somatic mutational landscape in sporadic human cancers. Hum Genomics. 2017; 11(1):13. PMC: 5480124. DOI: 10.1186/s40246-017-0109-3. View

Peters H, Hess D, Fahsold R, Schulke M . A novel mutation L1425P in the GAP-region of the NF1 gene detected by temperature gradient gel electrophoresis (TGGE). Mutation in brief no. 230. Online. Hum Mutat. 1999; 13(4):337. DOI: 10.1002/(sici)1098-1004(1999)13:4<337::aid-humu12>3.0.co;2-f. View

Liu A, Liu L, Chen S, Yang Y, Zhao H, Liu L . Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol. 2012; 228(6):1270-83. DOI: 10.1002/jcp.24282. View

Almeida M, Reis R, Calin G . MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. 2011; 717(1-2):1-8. DOI: 10.1016/j.mrfmmm.2011.03.009. View

10.

Lujambio A, Calin G, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D . A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A. 2008; 105(36):13556-61. PMC: 2528872. DOI: 10.1073/pnas.0803055105. View

11.

Mertens-Talcott S, Chintharlapalli S, Li X, Safe S . The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007; 67(22):11001-11. DOI: 10.1158/0008-5472.CAN-07-2416. View

12.

McDuff S, Dietrich J, Atkins K, Oh K, Loeffler J, Shih H . Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV. Cancer Med. 2019; 9(1):3-11. PMC: 6943166. DOI: 10.1002/cam4.2686. View

13.

Sakr M, Takino T, Sabit H, Nakada M, Li Z, Sato H . miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase. Gene. 2016; 587(2):155-62. DOI: 10.1016/j.gene.2016.04.058. View

14.

Guttilla I, White B . Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009; 284(35):23204-16. PMC: 2749094. DOI: 10.1074/jbc.M109.031427. View

15.

Chhabra R, Dubey R, Saini N . Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer. 2010; 9:232. PMC: 2940846. DOI: 10.1186/1476-4598-9-232. View

16.

Wang T, Xu Z . miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem Biophys Res Commun. 2010; 402(2):186-9. DOI: 10.1016/j.bbrc.2010.08.031. View

17.

Shi L, Fei X, Wang Z, You Y . PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway. In Vitro Cell Dev Biol Anim. 2015; 51(10):1047-55. DOI: 10.1007/s11626-015-9931-x. View

18.

Feng J, Iwama A, Satake M, Kohu K . MicroRNA-27 enhances differentiation of myeloblasts into granulocytes by post-transcriptionally downregulating Runx1. Br J Haematol. 2009; 145(3):412-23. DOI: 10.1111/j.1365-2141.2009.07632.x. View

19.

Ratner N, Miller S . A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer. 2015; 15(5):290-301. PMC: 4822336. DOI: 10.1038/nrc3911. View

20.

Giunti L, Da Ros M, De Gregorio V, Magi A, Landini S, Mazzinghi B . A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation. Mol Clin Oncol. 2019; 10(3):331-338. PMC: 6388501. DOI: 10.3892/mco.2019.1795. View